113 related articles for article (PubMed ID: 34388250)
1. Expression of STAT6 and Phosphorylated STAT6 in Primary Central Nervous System Lymphomas.
Karpathiou G; Ferrand E; Camy F; Babiuc SM; Papoudou-Bai A; Dumollard JM; Cornillon J; Peoc'h M
J Neuropathol Exp Neurol; 2021 Sep; 80(9):830-834. PubMed ID: 34388250
[TBL] [Abstract][Full Text] [Related]
2. STAT6 and phosphorylated STAT6 are differentially expressed in lymphomas.
Karpathiou G; Ferrand E; Papoudou-Bai A; Camy F; Honeyman F; Dumollard JM; Peoc'h M
Pathol Res Pract; 2022 Jan; 229():153697. PubMed ID: 34839096
[TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic analysis of STAT6(YE361) in Hodgkin lymphoma.
Yang LQ; Wang L; Zuo LK; Ma ZP; Yan SF; Yang MH; Liu B; Li XX
Pathol Res Pract; 2022 Mar; 231():153781. PubMed ID: 35121362
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of STAT6
Van Slambrouck C; Huh J; Suh C; Song JY; Menon MP; Sohani AR; Duffield AS; Goldberg RC; Dama P; Kiyotani K; Godfrey J; Fitzpatrick C; Kline J; Smith SM; Jaffe ES; Hartmann S; Venkataraman G
Mod Pathol; 2020 May; 33(5):834-845. PubMed ID: 31822802
[TBL] [Abstract][Full Text] [Related]
5. Hemangiopericytomas in the Central Nervous System: A Multicenter Study of Korean Cases with Validation of the Usage of STAT6 Immunohistochemistry for Diagnosis of Disease.
Choi J; Park SH; Khang SK; Suh YL; Kim SP; Lee YS; Kwon HS; Kang SG; Kim SH
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):954-961. PubMed ID: 27444109
[TBL] [Abstract][Full Text] [Related]
6. Primary central nervous system lymphomas express immunohistochemical factors of autophagy.
Karpathiou G; Babiuc SM; Camy F; Ferrand E; Papoudou-Bai A; Dumollard JM; Cornillon J; Peoc'h M
Sci Rep; 2021 Nov; 11(1):22259. PubMed ID: 34782660
[TBL] [Abstract][Full Text] [Related]
7. STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology.
Karpathiou G; Papoudou-Bai A; Ferrand E; Dumollard JM; Peoc'h M
Pathol Res Pract; 2021 Jul; 223():153477. PubMed ID: 33991851
[TBL] [Abstract][Full Text] [Related]
8. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival in primary CNS lymphoma treated by high-dose methotrexate monochemotherapy: role of STAT6 activation as prognostic determinant.
Yang SH; Lee KS; Kim IS; Hong JT; Sung JH; Son BC; Lee SW; Hong YK
J Neurooncol; 2009 Mar; 92(1):65-71. PubMed ID: 19030780
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of c-Myc in primary central nervous system lymphoma of Thais.
Assanasen T; Shuangshoti S; Nilyai S; Wannakrairot P; Ruangvejvorachai P; Sawatdee R; Sangprakarn S
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S40-6. PubMed ID: 17718267
[TBL] [Abstract][Full Text] [Related]
11. STAT6 activation correlates with cerebrospinal fluid IL-4 and IL-10 and poor prognosis in primary central nervous system lymphoma.
Mondello P; Cuzzocrea S; Arrigo C; Pitini V; Mian M; Bertoni F
Hematol Oncol; 2020 Feb; 38(1):106-110. PubMed ID: 31524297
[No Abstract] [Full Text] [Related]
12. MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
Kim S; Nam SJ; Kwon D; Kim H; Lee E; Kim TM; Heo DS; Park SH; Kim CW; Jeon YK
BMC Cancer; 2016 Jun; 16():363. PubMed ID: 27286976
[TBL] [Abstract][Full Text] [Related]
13. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
[TBL] [Abstract][Full Text] [Related]
14. Programmed Cell Death Ligand 1 Expression in Primary Central Nervous System Lymphomas: A Clinicopathological Study.
Hayano A; Komohara Y; Takashima Y; Takeya H; Homma J; Fukai J; Iwadate Y; Kajiwara K; Ishizawa S; Hondoh H; Yamanaka R
Anticancer Res; 2017 Oct; 37(10):5655-5666. PubMed ID: 28982883
[TBL] [Abstract][Full Text] [Related]
15. Analysis of primary central nervous system large B-cell lymphoma in the era of high-grade B-cell lymphoma: Detection of two cases with MYC and BCL6 rearrangements in a cohort of 12 cases.
Pina-Oviedo S; Bellamy WT; Gokden M
Ann Diagn Pathol; 2020 Oct; 48():151610. PubMed ID: 32889391
[TBL] [Abstract][Full Text] [Related]
16. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
Sugita Y; Furuta T; Ohshima K; Komaki S; Miyoshi J; Morioka M; Abe H; Nozawa T; Fujii Y; Takahashi H; Kakita A
Neuropathology; 2018 Apr; 38(2):125-134. PubMed ID: 29067721
[TBL] [Abstract][Full Text] [Related]
17. BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma.
Makino K; Nakamura H; Shinojima N; Kuroda JI; Yano S; Mikami Y; Mukasa A
J Neurooncol; 2018 Oct; 140(1):115-121. PubMed ID: 29968039
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features of primary diffuse large B-cell lymphoma of the central nervous system - strong EZH2 expression implying diagnostic and therapeutic implication.
Guo S; Bai Q; Rohr J; Wang Y; Liu Y; Zeng K; Yu K; Zhang X; Wang Z
APMIS; 2016 Dec; 124(12):1054-1062. PubMed ID: 27807891
[TBL] [Abstract][Full Text] [Related]
19. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
[TBL] [Abstract][Full Text] [Related]
20. Sialic acid-binding immunoglobulin-like lectin-15 expression on peritumoral macrophages is a favorable prognostic factor for primary central nervous system lymphoma patients.
Fudaba H; Momii Y; Hirakawa T; Onishi K; Asou D; Matsushita W; Kawasaki Y; Sugita K; Fujiki M
Sci Rep; 2021 Jan; 11(1):1206. PubMed ID: 33441719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
